News
Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...
Eli Lilly stock dips despite strong Q2 results. Read my insights on obesity drug market dominance and why this selloff in LLY ...
Novo Nordisk stock was downgraded to Neutral from Buy by UBS analysts, who cited the threat posed by Eli Lilly as just one ...
Novo, valued at $650 billion in June last year, has shed over two-thirds of its value since. Its latest market cap is around ...
Trial shows that risk of a major adverse cardiovascular event is eight per cent lower in people on new therapy ...
The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback